Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches

被引:72
作者
Mevel, Katell
Desgranges, Beatrice
Baron, Jean-Claude
Landeau, Brigitte
De la Sayette, Vincent
Viader, Fausto
Eustache, Francis
Chetelat, Gael
机构
[1] Univ Caen, CHU Cote Nacre, Inserm E0218,Lab Neuropsychol, EPHE,GIP Cyceron, F-14074 Caen, France
[2] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England
[3] CHU Cote Nacre, Dept Neurol, Caen, France
关键词
D O I
10.1016/j.neuroimage.2007.04.048
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While the hippocampus is constantly reported as the site of earliest and highest structural alteration in Alzheimer's disease (AD), findings regarding the metabolic status of this region are rather heterogeneous. It has been proposed that only a time-consuming individual region-of-interest (ROI) approach would allow the detection of hypometabolism in this complex and small area. Our main goal with this study is to assess whether more automatic and clinically useful methods would be sensitive enough when considering other methodological confounds. From a single PET data set collected in 28 patients with amnestic Mild Cognitive Impairment (aMCI) and 19 controls, we assessed the effects of partial volume effect (PVE) correction, scaling (using vermis or global means), and analysis method (individual ROI versus more automatic template-based ROI or voxel-based approaches) on hippocampal hypometabolism detection in aMCI. PVE correction and scaling both showed a significant effect on group comparison, while the analysis method (individual versus template-based ROT) surprisingly did not. Hippocampal metabolic decrease was significant in all vermis-scaled conditions, and more so after PVE correction. Our findings highlight the crucial relevance of using reference-region-based (instead of global) scaling, and the higher sensitivity of PVE-corrected PET measures, to detect hippocampal hypometabolism in aMCI. They also show that hippocampal metabolic decline can be detected using template-based ROI as well as voxel-based methods. These findings have clinical relevance since they support the validity of more automatic and time-saving approaches to assess hippocampal metabolism changes in aMCI and early AD. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 30 条
[1]   Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies [J].
Alexander, GE ;
Chen, K ;
Pietrini, P ;
Rapoport, SI ;
Reiman, EM .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (05) :738-745
[2]   Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease [J].
Anchisi, D ;
Borroni, B ;
Franceschi, M ;
Kerrouche, N ;
Kalbe, E ;
Beuthien-Beumann, B ;
Cappa, S ;
Lenz, O ;
Ludecke, S ;
Marcone, A ;
Mielke, R ;
Ortelli, P ;
Padovani, A ;
Pelati, O ;
Pupi, A ;
Scarpini, E ;
Weisenbach, S ;
Herholz, K ;
Salmon, E ;
Holthoff, V ;
Sorbi, S ;
Fazio, F ;
Perani, D .
ARCHIVES OF NEUROLOGY, 2005, 62 (11) :1728-1733
[3]   Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease [J].
Buchert, R ;
Wilke, F ;
Chakrabarti, B ;
Martin, B ;
Brenner, W ;
Mester, J ;
Clausen, M .
JOURNAL OF NEUROIMAGING, 2005, 15 (04) :348-355
[4]   FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment [J].
Chételat, G ;
Eustache, F ;
Viader, F ;
De la Sayette, V ;
Pélerin, A ;
Mézenge, F ;
Hannequin, D ;
Dupuy, B ;
Baron, JC ;
Desgranges, B .
NEUROCASE, 2005, 11 (01) :14-25
[5]   Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment [J].
Chételat, G ;
Desgranges, B ;
de la Sayette, V ;
Viader, F ;
Berkouk, K ;
Landeau, B ;
Lalevée, C ;
Le Doze, F ;
Dupuy, B ;
Hannequin, D ;
Baron, JC ;
Eustache, F .
BRAIN, 2003, 126 :1955-1967
[6]   Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET) [J].
de Leon, MJ ;
Convit, A ;
Wolf, OT ;
Tarshish, CY ;
DeSanti, S ;
Rusinek, H ;
Tsui, W ;
Kandil, E ;
Scherer, AJ ;
Roche, A ;
Imossi, A ;
Thorn, E ;
Bobinski, M ;
Caraos, C ;
Lesbre, P ;
Schlyer, D ;
Poirier, J ;
Reisberg, B ;
Fowler, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10966-10971
[7]   Hippocampal formation glucose metabolism and volume losses in MCI and AD [J].
De Santi, S ;
de Leon, MJ ;
Rusinek, H ;
Convit, A ;
Tarshish, CY ;
Roche, A ;
Tsui, WH ;
Kandil, E ;
Boppana, M ;
Daisley, K ;
Wang, GJ ;
Schlyer, D ;
Fowler, J .
NEUROBIOLOGY OF AGING, 2001, 22 (04) :529-539
[8]   Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease [J].
deLeon, MJ ;
McRae, T ;
Rusinek, H ;
Convit, A ;
DeSanti, S ;
Tarshish, C ;
Golomb, J ;
Volkow, N ;
Daisley, K ;
Orentreich, N ;
McEwen, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3251-3259
[9]   The neural basis of intrusions in free recall and cued recall:: A PET study in Alzheimer's disease [J].
Desgranges, A ;
Baron, JC ;
Giffard, N ;
Chételat, G ;
Lalevée, C ;
Viader, F ;
de la Sayette, V ;
Eustache, F .
NEUROIMAGE, 2002, 17 (03) :1658-1664
[10]   The neural substrates of memory systems impairment in Alzheimer's disease -: A PET study of resting brain glucose utilization [J].
Desgranges, B ;
Baron, JC ;
de la Sayette, V ;
Petit-Taboué, MC ;
Benali, K ;
Landeau, B ;
Lechevalier, B ;
Eustache, F .
BRAIN, 1998, 121 :611-631